#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Parkinson's disease Testicular leiomyosarcoma Primary biliary cholangitis Choroidal dystrophy Transitional cell cancer of the renal pelvis and ureter Acute lymphocytic leukaemia Antiphospholipid syndrome Severe myoclonic epilepsy of infancy Rett syndrome Henoch-Schonlein purpura nephritis Cardiomyopathy Marginal zone lymphoma Chronic hepatitis B Cerebellar ataxia Noonan syndrome More trials…

    Learn about Rare Diseases

    Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Diagnostics Toxic epidermal necrolysis – Trials in Disease Rosai-Dorfman syndrome – Diagnostics Von Willebrand’s disease Breast angiosarcoma metastatic – Treatment Mantle cell lymphoma stage II – Trials in Disease Mantle cell lymphoma stage III – Trials in Disease Netherton’s syndrome – Life with Disease Short-bowel syndrome – Treatment Hereditary hypophosphataemic rickets – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Dc-806 Protein C Volrustomig Human Cancellous Bone Amifostine Thiol ZINC CHLORIDE Avibactam Tiaprofenic Acid Tetrahydrouridine SAROGLITAZAR HEMIMAGNESIUM Benzathine Benzylpenicillin Ibrutinib Alizapride DAPIGLUTIDE Coffee Charcoal TRIACYLGLYCEROL LIPASE Hydrocortisone Hemisuccinate L-Glutamic Acid Prednisone Ertapenem Sodium More therapies…

    Learn about Your Condition

    Osteosarcoma recurrent Haemoglobinuria Poor quality sleep Primary hyperoxaluria Hepatic angiosarcoma Metachromatic leukodystrophy Hepatocellular carcinoma Leber's congenital amaurosis Fatty acid oxidation disorder Open angle glaucoma Vesicoureteric reflux Acoustic neuroma Wiskott-Aldrich syndrome Immune-mediated renal disorder Aortic stenosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Small cell lung cancer

  • Evaluation of HLX10 Combined with Chemotherapy and Radiotherapy in Limited-Stage Small Cell Lung Cancer: A Phase III Randomized, Double-Blind Study

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Small cell lung cancer
    Austria Czechia Germany Greece Hungary Latvia +3

  • Study of Durvalumab for Patients with Limited Stage Small Cell Lung Cancer After Chemoradiotherapy

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Durvalumab
    Spain

  • Study of Tarlatamab Treatment in Patients with Small Cell Lung Cancer: Evaluation of Different Dosing Schedules

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Small cell lung cancer
    Investigated Drugs:
    • Siltuximab
    • Tarlatamab
    Belgium France Germany Greece Italy Spain

  • Study on the Safety and Effectiveness of PF-07104091 Alone or with Fulvestrant, Letrozole, and Palbociclib for Patients with Advanced Breast, Ovarian, or Lung Cancer

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Ovarian cancer
    • Breast cancer
    • Small cell lung cancer
    Investigated Drugs:
    • [(1R,3S)-3-[3-[[5-(Methoxymethyl)-2-Methylpyrazole-3-Carbonyl]Amino]-1H-Pyrazol-5-Yl]Cyclopentyl]N-Propan-2-Ylcarbamate Monohydrate
    • Letrozole
    • Palbociclib
    Bulgaria

  • Study of CYC140 oral medication for patients with advanced solid tumors and lymphoma

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Gallbladder cancer
    • B-cell lymphoma
    • Bladder cancer
    Investigated Drugs:
    • Cyc140 Monohydrochloride Monohydrate
    Spain

  • Study of Nivolumab alone or combined with Ipilimumab for patients with advanced solid tumors (breast, gastric, pancreatic, lung, bladder, or ovarian cancer)

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Pancreatic carcinoma
    • Bladder cancer
    • Gastric cancer
    Investigated Drugs:
    • Ipilimumab
    • Nivolumab
    Germany
Previous Page
1 2 3 4 5 6
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!